Compare AU

Compare F100 vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Ftse 100 ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Ftse 100 ETF (F100) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

F100

CURE

Popularity

Low

Low

Pearlers invested

47

85

Median incremental investment

$994.58

$616.00

Median investment frequency

Monthly

Monthly

Median total investment

$3,521.10

$1,520.68

Average age group

> 35

> 35


Key Summary

F100

CURE

Strategy

F100.AX was created on 2019-07-12 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the price and income performance of the FTSE 100 Index (before fees and expenses). The Index provides exposure to the largest 100 comoanies traded on the London Stock Exchange, based on their market capitalisation.

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

ASTRAZENECA PLC (8.94 %)

SHELL PLC (8.77 %)

HSBC HOLDINGS PLC (6.17 %)

Incyte Corp (3.14 %)

United Therapeutics Corp (2.87 %)

Gilead Sciences Inc (2.86 %)

Top 3 industries

Financials (17.65 %)

Consumer Staples (17.44 %)

Energy (13.29 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

Management fee

0.45 %

0.45 %


Key Summary

F100

CURE

Issuer

BetaShares

Global X

Tracking index

FTSE 100 Index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.45 %

0.45 %

Price

$12.10

$54.31

Size

$333.378 million

$39.185 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

3.01 %

4.24 %

Market

ASX

ASX

First listed date

16/07/2019

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

F100

CURE

Popularity

Low

Low

Pearlers invested

47

85

Median incremental investment

$994.58

$616.00

Median investment frequency

Monthly

Monthly

Median total investment

$3,521.10

$1,520.68

Average age group

> 35

> 35


Pros and Cons

F100

CURE

Pros

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower distribution yield

  • Lower price growth

F100

CURE

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home